Author Correction: Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature

Li, Jia Wei; Zhang, Kai; Shi, Zhao Ting; Zhang, Xun; Xie, Juan; Liu, Jun Ying; Chang, Cai

doi:10.1038/s41598-020-61260-3

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study, which indicated that TNBC is unlikely to exhibit posterior acoustic attenuating, found no statistically significant difference between the TNBC group and the non-TNBC group regarding the proportion of post-acoustic echo alterations [26] . Li Jiawei et al's analysis of data from 104 cases of TNBC and 456 examples of non-TNBC revealed additional confirmation of the independent ultrasonic characteristics of TNBC, including regular shape, absence of needle-like/angular edges, posterior acoustic enhancement, and lack of calcification [17] .…”

Section: Two-dimensional Grayscale Ultrasound (2d-us)mentioning

confidence: 96%

“…Breast lesions, both benign and malignant breast lesions, can be more accurately diagnosed using multimodal ultrasonography [12][13][14][15][16] . TNBC frequently exhibits the characteristics of benign tumors on conventional ultrasound imaging, even though various molecular subtypes of breast cancer might exhibit diverse appearances on sonogram s [17] . Therefore, routine ultrasound examination of TNBC is prone to misdiagnosis, which can impact both treatment and prognosis.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Status and Progress of Multimodal Ultrasound Diagnosis of Triple-negative Breast Cancer

2023

IJFM

View full text Add to dashboard Cite

Breast cancer is a highly heterogeneous cancer that is exceptionally harmful to women. It is generally divided by immunohistochemistry into four primary molecular subtypes: triple-negative (TN), human epidermal growth factor receptor 2 (HER2) overexpression, luminal A, and luminal B. Different breast cancer molecular subtypes exhibit diverse biological traits, clinical symptoms, therapeutic responses, and prognoses. Among them, triple-negative breast cancer (TNBC) is a highly malignant subtype with no particular treatment modalities and an inferior prognosis. As diverse ultrasonographies can offer complementing information on various features of breast cancer, multimodal ultrasonography provides a more reliable method for predicting TNBC than conventional ultrasound alone. This article reviews the research status and progress of multimodal ultrasound diagnostic techniques such as traditional ultrasound combined with sonoelastography (SE), contrast ultrasonography (CEUS), three-dimensional ultrasound (3D-US) and superb microvascular imaging (SMI) in predicting triple-negative breast cancer. It aims to use ultrasound diagnosis technology to predict TNBC and provide a reference for guiding clinical treatment and enhancing prognosis.

show abstract

Section: Two-dimensional Grayscale Ultrasound (2d-us)mentioning

confidence: 96%

Section: Introductionmentioning

confidence: 99%

Status and Progress of Multimodal Ultrasound Diagnosis of Triple-negative Breast Cancer

2023

IJFM

View full text Add to dashboard Cite

show abstract

“…On the other hand, Li et al, analysing the material of 543 breast cancers (104 TNBC vs. 439 non-TNBC), showed that, statistically speaking, TNBC with higher histological malignancy (G3-grade 3) often present with benign lesions features. Therefore, they may be disqualified from biopsy, especially in young patients (15) . Authors of this study demonstrated the presence of the following features in TNBC: regular shape (OR = 1.8), no spiculated/angular margins (OR = 2.09), acoustic enhancement behind the lesion (2.49), and lack of calcifications (OR = 1.95), which are usually associated with benign lesions.…”

Section: Introductionmentioning

confidence: 99%

Immunohistochemical subtypes of the breast cancer in the ultrasound and clinical aspect – literature review

et al. 2022

View full text Add to dashboard Cite

Breast cancer is a heterogeneous disease both in its clinical and radiological manifestations and response to treatment. This is largely due to the polymorphism of the histological types as well as diversified molecular profiles of individual breast cancer types. Progress in the understanding of the biology of breast cancer was made with the introduction of immunohistochemical research into the common practice. On this basis, four main breast cancer subtypes were distinguished: luminal A, luminal B, HER2 positive (human epidermal growth factor receptor-2 positive), and triple negative cancer. The classification of a tumour to an appropriate subtype allows for the optimisation of treatment (surgery or pre-operative chemotherapy). In this study, the authors present different patterns of breast cancer subtypes in ultrasound examination and differences in their treatment, with particular emphasis on aggressive breast cancer subtypes, such as triple negative or HER2 positive. They can, unlike the luminal subtypes, create diagnostic problems. Based on multifactorial analysis of the ultrasound image, with the assessment of lesion margins, orientation, shape, echogenicity, vascularity, the presence of calcifications or assessment by sonoelastography, it is possible to initially differentiate individual subtypes.

show abstract

Author Correction: Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature

Cited by 2 publications

References 0 publications

Status and Progress of Multimodal Ultrasound Diagnosis of Triple-negative Breast Cancer

Status and Progress of Multimodal Ultrasound Diagnosis of Triple-negative Breast Cancer

Immunohistochemical subtypes of the breast cancer in the ultrasound and clinical aspect – literature review

Contact Info

Product

Resources

About